| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.04 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |